PreveCeutical Medical Competitors and Similar CompaniesClear all

PreveCeutical Medical's competitors and similar companies include Delta-Fly Pharma, Cadent Therapeutics, ProPhase Labs and Primmune Therapeutics.

	PreveCeutical Medical PreveCeutical Medical is a health sciences company that develops preventive and curative therapies utilizing organic and natural identical products.	Delta-Fly Pharma Delta-Fly Pharma 株式会社（デルタフライファーマ is a manufacturer and seller of anti-cancer agents and other products.	Cadent Therapeutics Cadent Therapeutics is a neuroscience company that develops a pipeline of medicines.	ProPhase Labs ProPhase Labs develops and markets clinically proven remedies including the highly effective Cold-EEZE and Kids-EEZE product lines.	Primmune Therapeutics Primmune Therapeutics is a company that provides drug design and development solutions.
Founding Date	Founding Date 2009	Founding Date 2010	Founding Date 2017	Founding Date 1981	Founding Date 2017
Type	Type Public	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare drug development healthtech medtech	Tags Healthcare drug development medtech	Tags Healthcare drug development medtech	Tags Healthcare Manufacturing & Industrial drug development healthtech medtech	Tags Healthcare biotech drug development oncology
Locations	Locations HQ	Locations HQ	Locations Cambridge, US HQ	Locations Doylestown, US HQ Old Bridge, US Uniondale, US	Locations Carlsbad, US HQ
Employees	Employees N/A	Employees N/A	Employees 264% increase	Employees 477% increase	Employees 1011% increase
Valuation ($)	Valuation ($) 9.7 m	Valuation ($) 29.5 m	Valuation ($) N/A	Valuation ($) 42.9 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $4.3m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods (¥1.6m) (FY, 2025)	Cost of goods N/A	Cost of goods $3m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥1.6m (FY, 2025)	Gross profit N/A	Gross profit $1.4m (FY, 2025)	Gross profit N/A
Net income	Net income ($1.2m) (FY, 2024)	Net income (¥1.7b) (FY, 2025)	Net income N/A	Net income ($14.7m) (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 40m (over 7 years ago)	Latest funding round N/A	Latest funding round $ 7m (about 6 years ago)
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 51.7m	Total funding raised N/A	Total funding raised $ 8.5m